You must be logged in to view this report.
The module you are trying to access does not exist.

PART 6: MODULE 2 ASSESSMENT

  • Assessment: 10 multiple-choice questions
Duration: 10 min (approx.)

PART 5: MODULE SUMMARY AND TAKEAWAYS

  • Summary – the OCP
  • Summary – SLCNs
Duration: 5 min (approx.)

PART 4: DIAGNOSIS, STAGING AND TREATMENT PLANNING

  • First specialist medical appointment
  • Clinical guidelines
  • Diagnostic work up
  • Biopsy procedures
  • Liquid biopsies
  • TNM staging in lung cancer
  • Biomarkers in lung cancer
  • Treatment planning
  • Performance status considerations
Duration: 15-25 min (approx.)

PART 3: PRESENTATION, INITIAL INVESTIGATIONS AND REFERRAL

  • Presentation and investigations
  • Urgency of investigation
  • Initial referral
  • Inbound referral processes at specialist services
  • SLCN activity prior to the first specialist appointment
Duration: 10-15 min (approx.)

PART 2: PREVENTION AND EARLY DETECTION

  • Advocacy and policy direction
  • Public health and health promotion campaigns
  • Lung cancer risk factors
  • Recommendations for preventing lung cancer
  • Variations in lung cancer outcomes
  • Screening for lung cancer
Duration: 5-15 min (approx.)

PART 1: AN OVERVIEW OF THE OPTIMAL LUNG CANCER PATIENT PATHWAY

  • The Optimal Care Pathway (OCP)
  • Seven principles of care
  • Steps of care in the OCP
  • Optimal care timeframes
  • Special population groups
Duration: 10-15 min (approx.)

MODULE 2 INTRODUCTION

  • Introduction
  • Recap: Learning outcomes
  • Recap: Module overview
Duration: 2 min (approx.)

INDUCTION EDUCATION SERIES OVERVIEW

  • Induction series introduction
  • Module series overview
  • Resources and assessment
Duration: 3 min (approx.)

PART 6: MODULE 1 ASSESSMENT

  • Assessment: 10 multiple-choice questions
Duration: 10 min (approx.)

PART 5: MODULE SUMMARY AND TAKEAWAYS

  • Summary
  • Summary – SLCNs
Duration: 5 min (approx.)

PART 4: THE ROLE OF THE SPECIALIST LUNG CANCER NURSE

  • High level expectations
  • Five domains of advanced practice nursing
  • Clinical care domain
  • Optimising health systems
  • Implementation of the SLCN role
Duration: 15-25 min (approx.)

PART 3: COMPLEXITIES OF LUNG CANCER

  • Equity of care
  • Stigma
  • Medical nihilism
Duration: 5-10 min (approx.)

PART 2: EPIDEMIOLOGY OF LUNG CANCER

  • Epidemiology
  • Incidence
  • Survival rates
  • Mortality
  • Burden of disease
  • LFA lung cancer blueprint 2.0
Duration: 5-10 min (approx.)

PART 1: BACK TO BASICS – WHAT IS LUNG CANCER?

  • Anatomy of the respiratory system
  • What is cancer?
  • Types of lung cancer
  • Small cell lung cancer
  • Non-small cell lung cancer
  • Gene mutations in lung cancer
  • Signs and symptoms of lung cancer
  • Mesothelioma
Duration: 15-25 min (approx.)

MODULE 1 INTRODUCTION

  • Introduction
  • Recap: Learning outcomes
  • Recap: Module overview
Duration: 2 min (approx.)

INDUCTION EDUCATION SERIES OVERVIEW

  • Induction series introduction
  • Module series overview
  • Resources and assessment
Duration: 3 min (approx.)

Post-learning survey and evaluation

After completing this module, we would like to understand your knowledge and understanding about the science behind CF and CFTR modulator therapy, as well as evaluate your experience and satisfaction with this module. The survey has a total of 9 mandatory questions and 2 optional questions. Please allow around 5 minutes to complete it.

Part 6: CFTR modulator therapies in practice

  • Clinical reflections - instructions
  • Who’s on your team?
  • Confirming CFTR gene variants and genetic test results
  • Interpreting genetic test results
  • Explaining CFTR mutations to patients
  • Module summary
Duration: 10-12 minutes (approx.)

Part 5: Therapeutic approaches targeting CFTR gene variants

  • Treatment evolution
  • Types of CFTR modulator therapies
  • F508del: a minimal function mutation that can be corrected
  • CFTR modulator discovery
  • Translational science in action: CFTR modulator development
Duration: 10-15 minutes (approx.)

Part 4: Impact of CFTR genotype on phenotype

  • Phenotype versus genotype
  • CFTR gene variants and CF disease phenotype
  • Relationship between CFTR function and phenotype
Duration: 5-10 minutes (approx.)

Part 3: Understanding CFTR variants – types of mutations and their impact

  • Variety of CFTR gene variants identified
  • CFTR quantity and function
  • Classes of CFTR gene variants
  • Classifying gene variants by function
  • Minimal function mutations
  • Impaired gating mutations
  • Residual function mutations
  • F508del characteristics
  • Useful resources
Duration: 10-15 minutes (approx.)

Part 2: Principles of transcription, translation, and genetic mutations

  • Central principle of molecular biology
  • Gene variants impact protein form and function
  • Ways genes can be altered
  • Gene variant naming formats
Duration: 10-15 minutes (approx.)

Part 1: Cystic fibrosis – an overview

  • CFTR gene mutations cause CF
  • Role CFTR protein
  • CFTR mutations are inherited
Duration: 5-10 minutes (approx.)

Introduction

  • CFTR mutations in CF: introduction
  • Learning outcomes
  • Module overview
Duration: 2 - 3 minutes (approx.)
« » page 1 / 5